GLP-1 RA-Related Facial Aging The rapid and significant weight loss induced by GLP-1 RAs often leads to a noticeable reduction in facial fat pad volume, along with a decline in skin collagen, elastin, and essential nutrients
Bringing closer the two seemingly different metabolisms makes it easier to get energy and oxidize the desired sources, such as fats
Safety & Side Effects of GLP-1 Microdosing GLP-1 microdosing is designed to be gentler than full-dose therapy, but its still a prescription medication and should be used under medical supervision
Tirzepatide is a newer GLP-1 and GIP receptor agonist that works on dual pathways to enhance weight loss and blood sugar control
Despite binding to different receptors, their effects converge on protein kinases (PKA, PKB, PKC) and transcription factors like PPAR-gamma, a key regulator of lipid metabolism
Effects of glucagon-like peptide-1 receptor agonists on incidence of hepatocellular carcinoma and liver decompensation in patients with diabetes: a systematic review and meta-analysis